Embryonic stem cells (ESCs) have attracted particular interest in regenerative medicine because of their unlimited self-renewal and multipotentiality for differentiation. Spontaneous differentiated ESCs display heterogeneous multipotent cell populations and generate teratomas in vivo, with process by which ESCs differentiate into specific lineages remaining unclear. In this study, we focused on the in vitro chondrocyte differentiation of ESCs through micro-mass without using an embryoid body (EB) step and observed the unique characteristics of cartilage formation coupled with endochondral ossification in vivo. This approach resulted in an aggressive loss of discordant cells by apoptosis, which was accompanied by significant changes in gene expression during the course of ESC differentiation into chondrocytes. Unlike EB formation where discordant cells remain trapped within aggregates, micro-mass permits cells to die, leave the group and/or form a new group in response to changes in gene expression. Our observations suggest that the cell death that accompanies ESC micro-mass differentiation helps purify a terminally differentiated cell population and selects for targeted end points within a suitable microenvironment.
Embryonic stem cells (ESCs) display self-renewal and pluripotency. 1, 2 In essence, ESCs offer a potentially unlimited supply of cells that may be driven down specific lineages to give rise to all cell types in the body. 3, 4 One of the challenges is to understand, control and develop an efficient and stable culture milieu for directing differentiation into lineage-specific progenitors or terminally differentiated cells. 5 As ESCs are derived from the inner cell mass, their differentiation can be used to recapitulate early embryonic development. To this end, two methods have been used in an attempt to stimulate the differentiation of ESCs into particular lineages. In one method, ESCs are allowed to form embryoid body (EB), mimicking the structure of the early embryo and creating suitable conditions for stochastic differentiation into mesoderm, ectoderm and endoderm. 3, 4, 6 Here, the addition of growth factors helps to influence differentiation toward particular lineages. In another, more recent method, ESCs have been differentiated directly on culture dishes without EB formation. 7 Recently, for example, it has been reported that such direct differentiation of human and mouse ESCs results in a significantly greater number of osteogenic cells. 8, 9 It has been reported that a supportive three-dimensional (3D) environment that more closely mimics chondrogenesis in vivo will induce distinct cellular behavior not present in monolayer culture. 10, 11 3D culture systems in the form of pellet or micromass have been frequently used for efficient chondrogenesis of mesenchymal stem cells (MSCs) or chondro-progenitor cells. 12 Several groups have described cell-intrinsic selection processes that take place during terminal differentiation. [13] [14] [15] In these studies, gene silencing allows for selection against discordant cell types and improves the purity of the desired target lineage. However, these studies also demonstrate that increased rates of apoptosis are not essential for this mechanism.
Here, we describe the chondrocyte differentiation of mouse ESCs using micro-mass culture in the absence of EB formation. Using this method, lineage restriction as demarcated by changes in lineage-specific gene expression is accompanied by massive apoptosis and the departure live cells, which form aggregates in suspension and subsequently adhere to form cartilage masses in vitro. In contrast to other methods that require 15 or 30 days to form chondrocytes in the absence or presence of EB formation, 16 ,17 using a micromass approach we have observed relatively pure masses of cartilage formed in 6 days.
Results
ESC morphology changes during micro-mass differentiation. Mouse ESCs were differentiated using a micro-mass method without EB formation. Using protocols similar to MSCs and chondro-progenitor cells, ESCs were cultured at high density (1.0 Â 10 5 cells per 10 ml drop) for 2 h. To examine cell growth and differentiation, we tested three media formulations: ITS-CS (insulin, transferrin and seleniumchondrogenic supplement), ITS-basic and FBS-CS. In the ITS-CS and ITS-basic treatment groups, cells aggregated spontaneously and lifted off the culture surface after 4 days (Figure 1Ab and Ae). In FBS-CS conditions, cells remained adhered and expanded peripherally to the central micro-mass (Figure 1Ah ). The floating aggregates observed under ITS-CS and ITS-basic conditions reattached within 24 h (day 5) and from this point onwards striking morphological differences between ITS-CS and ITS-basic were observed (Figure 1Ac and Ae). Under ITS-CS treatment, the aggregates retained a uniform and distinct margin (Figure 1Al and Ba), as compared to ITS-basic aggregates that displayed irregular and undefined margins (Figure 1Ao and Bb).
We observed clear differences in aggregate size and growth during the differentiation period and proceeded to examine this phenomenon. The average size of ESCs on day 0 was 16 mm, and decreased immediately after induction (14 mm on day 2) ( Figure 1C) . Moreover, there were two more distinct decreases in diameter, which occurred on day 3 Figure 1 Embryonic stem cell morphology during micro-mass culture. (A and B) Differentiation of ESCs using micro-mass culturing techniques resulted in dramatic changes in morphology between the three media conditions tested: ITS-CS (Aa-c and j-l), ITS-basic (Ad-f and m-o) and FBS-CS (Ag-i and p-r). On day 4 of differentiation, ITS-CS (Ab) and ITS-basic (Ae) detached from the substrate only to re-attach by day 6 (Ac and Af, respectively). FBS-CS cultured cells did not detach (Ah), but grew off the central cell mass (Ai). Increased magnification at the end of the micro-mass (Aj-r) shows the difference between ITS-CS (Al) and ITS-basic (Ao) after re-attachment, which is easily detected at lower magnifications (Ba and Bb, respectively). (C-E) The size of individual cells within the micro-mass pellets was assayed from day 0 to 7 of differentiation (C), as were culture expansion rates (D) and cell viability (E). Data are expressed as means ± S.D. (n ¼ 3) per lane.
#
Significant difference from ITS-basic, Po0.05 with Student's t-test. *Significant difference from FBS-CS, Po0.05 with Student's t-test. Scale bars represent 100 mm (10 mm) and day 6 (9 mm). Once the cells reached 6 mm, there was no significant increase or decrease in cell diameter ( Figure 1C ).
Viability of differentiated ESCs. We performed daily cell counts and viability assays on micro-mass cultures to track proliferation rates ( Figure 1D and E). Differentiated ESC growth rates increased gradually and peaked at day 5 in ITS-CS and FBS-CS conditions ( Figure 1D ). The growth rate of ITS-basic was slightly faster and peaked at day 4 of differentiation ( Figure 1D ). We then assayed the viability of the cells during induction and found that viability decreased immediately at the beginning of differentiation ( Figure 1E ). ITS-CS cultured cells retained a 75% viable cell density until day 5, after which the viability level decreased. In FBS-CS conditions, cell viability decreased gradually. It should also be noted that cell proliferation and viability rates between ITS-CS and ITS-basic treatment groups were significantly different ( Figure 1D and E).
Modulation of chondrogenesis in vitro. We further investigated chondrocyte differentiation within ESC micromass culture in vitro, by analyzing the accumulation of glycosaminoglycans (GAGs), and chondrocyte-specific mRNA and protein levels ( Figure 2 ). GAG levels were upregulated during the course of differentiation in ITS-CS conditions ( Figure 2A ). When normalized to DNA content, the corrected GAG/DNA analysis showed continuously low levels of GAGs in ITS-basic and FBS-CS treatment groups, as compared to ITS-CS conditions that displayed a significant increase in GAG/DNA levels ( Figure 2A ). Alcian Blue, which binds to proteoglycans, was used to visually confirm the GAG quantitative analysis. In ITS-CS conditions, Alican Blue staining was present at day 6 and was found in a cartilage nodule-like pattern ( Figure 2Ba ) and was also present at the edge of the micro-mass (Figure 2Bb ). This staining was retained when the aggregates lifted off the substrate and also during the re-attachment phase ( Figure  2Bc and d) .
In addition to GAG accumulation, we also examined the calcium content of the micro-mass cultures ( Figure 2C ). Increased calcium levels are normally associated with bone, however, cartilage does accumulate high levels of calcium, especially when undergoing endochondral ossification. 18, 19 Calcium levels in all treatment groups increased during differentiation, with higher calcium/DNA levels observed in the ITS-CS conditions ( Figure 2C ). Although GAG content is indicative of cartilage formation, we also chose to directly examine specific molecular markers known to be expressed during chondrocyte differentiation.
Semiquantitative RT-PCR demonstrated that micro-mass ESCs expressed Aggrecan and collagen (COL) 2 mRNA in all culture conditions ( Figure 2D ), both of which are early markers of chondrocyte differentiation. SOX9 mRNA, a transcription factor associated with chondrocyte differentiation was expressed in ITS-CS conditions at day 6 ( Figure 2D ). Interestingly, COL 10 mRNA, which is a late marker involved with hypertropic maturation, was also expressed strongly in ITS-CS conditions at day 6 ( Figure 2D ). Immunofluorescence was carried out in ITS-CS cells on day 7 and showed positive staining for Aggrecan ( Figure 2Ea ) and COL 2 ( Figure 2Ed ). COL 10 deposition was also observed, however, the staining was noticeably weaker (Figure 2Eg ).
Modulation of chondrogenesis in vivo.
We investigated the ability of micro-mass culture to differentiate into chondrocytes in vivo by injecting dissociated day 4 micromasses into SCID mice. These in vitro differentiated cells continued to proliferate and differentiate in vivo, and after 4 weeks, the extracted tissue retained defined margins ( Figure 3A) . The different culture conditions produced tissues that ranged in weight and area, 16 mg/0.015 cm 2 (ITS-CS; Figure 3Aa ), 606 mg/1.34 cm 2 (ITS-basic; Figure 3Ab ) and 200 mg/0.62 cm 2 (FBS-CS; Figure 3Ac ). On the basis of histology of these tissues, ESCs treated with ITS-CS generated cartilage and connective tissues (Figure 3Ba and Bb), and the cartilage became dark blue after Alcian Blue staining (Figure 3Bc and Bd). These differentiated cells were therefore also abundant with matrix consisting of GAG. On closer examination, we also observed bone and blood vessels in these extracted tissues ( Figure 3C ). The bone that was generated around the cartilage stained positive for Alizarin Red S (Figure 3Cd and Ce), and appeared to be the result of endochondral ossification during the 4-week in vivo differentiation period.
In contrast to the ITS-CS conditions, we observed a loss of tissue specificity in vivo within ITS-basic and FBS-CS conditions where cartilage, bone, fat, blood and muscle were produced ( Figure 3D and E). These two media conditions also formed teratomas in vivo where the ITS-CS treatment group did not.
Micro-mass specification toward chondrogenesis. Based on these results, we sought to profile the expression of lineage markers during differentiation under all three media conditions, using semiquantitative RT-PCR ( Figure 4A ). Using ITS-CS conditions, Nestin (ectoderm), AFP (endoderm) and Stella (reproduction) were downregulated and Brachyury (mesoderm) was upregulated at day 6. In addition, Osteocalcin (bone), aP2 (fat) and a-actin (muscle) were downregulated and Flk1 (mesoderm, blood vessel) was upregulated ( Figure 4A ). Interestingly, ITS-basic strongly expressed Osteocalcin on day 6 and only displayed weak bands for AFP, aP2 and a-actin, whereas FBS-CS expressed all targets tested ( Figure 4A ).
Aggressive apoptotic cell loss during chondrocyte differentiation. As ITS-CS cultures lost 25% of viable cells in vitro and also produced significantly smaller tissue masses in vivo, we sought to determine whether such aggressive cell loss might be explained by apoptosis ( Figure 4B and C). On day 4 of in vitro differentiation, we observed extensive TUNEL-positive cells in the margin of the micro-masses (Figure 4Ba) . By day 4, many aggregates detached and we observed TUNEL-positive cells remaining on the culture dish (Figure 4Bc ). Early apoptotic cells, which were Annexin V positive and propidium iodide (PI) negative, accounted for 15% of the total population on days 1 and 2, increasing to 25-35% on days 3-5 ( Figure 4C ).
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Discussion
The process of chondrogenic differentiation is influenced by a number of growth factors, including TGF-b and/or BMPs, and is measured by the sequential expression of specific matrix components. 20 Earlier, we and others have developed methods to differentiate ESCs into chondrocytes by exposing EBs to TGF-b and/or BMP-2. 16, 19, [20] [21] [22] [23] [24] Using EB differentiation, it takes approximately 30 days to express markers of chondrocyte differentiation, including Aggrecan and COL 2, 16 as compared to other methods that remove the EB step that require only 15 days in culture. 17 It is important to note, however, that the previous report describing ESC-derived chondrogenesis without EB formation does not provide any in vivo data that prove the generation of functional cartilage. 17 Two recent observations influenced our decision to explore ESC chondrocyte differentiation using micro-mass culture and avoiding the EB step. First, it was recently reported that ESCs have the capacity to differentiate spontaneously into osteoblasts without EB formation and offering the advantage of streamlining differentiation. 8, 9 Second, 3D high-density micro-mass culture also allows immediate cell condensation to form cartilage-like nodules 25 and is commonly used in the chondrocyte differentiation of MSCs and chondrogenic progenitors. [10] [11] [12] To examine the capacity of ESCs to differentiate toward chondrogenesis, we explored the use of the CSs TGF-b and BMP-2 in minimal defined media supplemented with ITS, ingredients commonly found in serum replacement formulations. Although we attempted to completely remove serum from the ITS formulations (i.e. ITS-basic and ITS-CS), 20, 23 we observed that 1% FBS was necessary to facilitate ESC attachment in micro-mass spots. With the significant cell death and/or dispersal, which occurred under ITS conditions, we have not explored whether 1% FBS can be removed once micro-masses formed. Indeed, this cell death/dispersal was not observed in FBS-CS conditions, where cultures are supplemented with normal levels of FBS.
Under these culture conditions, micro-mass ESCs expanded and changed morphology. Under both ITS-CS and ITS-basic conditions, a significant number of cells 
weeks after injection, the resulting tissue was excised, measured (A), and histologically stained (B-E). ITSbasic and FBS-CS conditions resulted in large tissue masses (Ab and c), whereas the size of tissue masses was relatively restricted under ITS-CS conditions. Under ITS-CS conditions, cartilage and connective tissue formed in vivo (Ba-d). ITS-CS-derived cartilage stained positive for Alcian Blue (Bc and d)
. H&E staining of tissue section viewed at a higher magnification showed that not only cartilage but also blood and bone are detected in ITS-CS (Ca). ITS-CS tissue sections stained with H&E (Cb). Alcian Blue staining was positive (Cc), demonstrating the presence of cartilage. Alizarin Red S staining of tissue section (Cd) showed presence of bone. Alcian Blue co-staining with Alizarin Red S shows interaction between bone and cartilage tissues (Ce). Under ITS-basic conditions, the teratomas contained cartilage (Da), bone (De), fat (Db), muscle (Dc) and blood vessels (Dd). Under FBS-CS conditions, the teratomas contained cartilage (Ea), fat (Eb), muscle (Ec) and blood vessel (Ed). Scale bars represent 50 mm Scale bars represent 100 mm. (C) Annexin V-FITC/PI labeling was used to detect and quantify apoptotic cells in ITS-CS conditions over differentiation. In total, 10 000 events were registered per sample
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After reattachment of aggregates in ITS-CS and ITS-basic conditions, we observed striking morphological differences between CS and basic conditions ( Figure 1B) . Unlike ITS-basic aggregates that displayed a rather disorganized configuration, ITS-CS reattachments appeared highly organized, bearing strikingly sharp margins. In addition, only ITS-CS-treated cells expressed cartilage-specific extracellular matrix proteins and SOX9, a transcription factor expressed during chondrogenesis (Figure 2) . During the process of differentiation in vitro, ITS-CS-treated cells differentiated into hypertrophic chondrocyte and mineralized. 19, 21 It is likely that the spontaneous aggregates that formed in ITS-CS developed a supportive 3D environment that more closely mimicked chondrogenesis in vivo. Injection of ITS-CS-treated cells into SCID mice resulted in small tissue masses comprised predominantly of cartilage ( Figure 3A and B) . In contrast, cells derived from ITS-basic and FBS-CS conditions resulted in teratomas ( Figure 3D and E). Although we also observed small amounts of blood and bone tissue in ITS-CSderived tissue ( Figure 3C ), we attribute this to endochondral ossification, a natural process whereby cartilage is replaced by bone tissue following vascular invasion. 20, 24 This observation is not unprecedented, and may even occur during in vitro differentiation. 16 This latter observation may help to explain why we detect some mineralization in ITS-CS cultures ( Figure 2C ), despite the clear absence of osteoblast marker (i.e. Osteocalcin) expression (Figure 4Ae) .
Only under ITS-CS conditions, did we see a progressive loss of ectodermal, endodermal and germ-cell marker expression and a concomitant increase in mesodermal marker expression. By day 6 of differentiation, evidence of bone, fat and skeletal muscle was non-existent. However, evidence of blood vessel differentiation persisted, as detected by the expression of Flk1. This result may help to explain the notion of endochondral ossification, which we observed in vivo.
In MSC differentiation, it has been suggested that the downregulation of unrelated phenotypic markers and cellular properties results from negative selection that is manifested by a combination of apoptosis and/or transcriptional regulation during the specific-lineage differentiation.
14 It stands to reason that a similar process may operate during ESC differentiation. We observed a massive decrease of cell viability following induction, which continued until day 6 ( Figure 1E ). Annexin apoptosis detection by FACScan analysis demonstrated that early apoptotic cells increased within the population immediately after induction and again at day 3 ( Figure 4C ). More aggressive cell loss appeared to start at day 3, which was accompanied by a decrease in average diameter of live cells in ITS-CS conditions ( Figure 1C) . A decrease in cell diameter is an early hallmark of apoptosis. 26 This, coupled with the TUNEL analysis ( Figure 4B ), implies an increase in cell death during the onset of the differentiation protocol. We suspect that if we allowed the experiment to proceed for a longer period of time, we would observe an increase in cell diameter in the ITS-CS treatment group indicative of chondrocyte differentiation. 27 The apoptotic cells appeared in the edge of micro-masses and remained on the culture surface after aggregates detached ( Figure 4B ). These results demonstrated that aggressive cell loss by apoptosis occurred during chondrogenic differentiation. We suggest that differentiation may not only require the increase of phenotypespecific cells, as manifested by the expression of lineagespecific markers, but also the decrease of discordant cells as mediated by apoptosis. ESCs might undergo a lineagespecific differentiation resulting in apoptosis of discordant cells along with changes in cellular morphology and microenvironment ( Figure 5 ). This ability of discordant cells to die or depart may help to explain the accelerated differentiation/ development occurring within micro-mass culture. For example, such behaviors may not be possible with cells trapped within EBs. Hence differentiation/development within EBs may be delayed through a process of cellular negotiation where differentiating cells more slowly find their way through compromise.
Materials and Methods
Mouse ESC culture. The D3 mouse ESC line 28 was cultured on mitomycin Ctreated (10 mg/ml, 37 1C for 2 h; Sigma) mouse embryonic fibroblast feeder layers on gelatin-coated tissue culture dishes. 29, 30 ESC medium consisted of high glucose DMEM (4.5 g glucose/l; Gibco) containing 15% FBS (Gibco), 1% non-essential amino acids (NEAA; Invitrogen), 50 U/ml penicillin and 50 mg/ml streptomycin (Pen/Strep; Invitrogen), 0.1 mM 2-mercaptoethanol (bME; Invitrogen) and 1000 U/ml leukemia inhibitory factor (Invitrogen), as described earlier. 31 Micro-mass culture. Micro-mass culture was performed as described earlier. 12 Briefly, ESCs were dissociated using 0.1% trypsin-EDTA. The dissociated cells were cultured at a high density of 1.0 Â 10 5 cells per 10 ml spot for 2 h. After incubation, medium was gently added to each dish so as to not dissociate the aggregates. For chondrocyte differentiation, we used three media Figure 5 Cell selection and elimination during chondrogenic differentiation of ESCs in micro-mass. Guided differentiation of ESCs can be achieved, in part, due to the progressive loss of discordant cells coupled within induction into the chondrocyte lineage
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A Yamashita et al containing the same base: DMEM, 1% NEAA, Pen/Strep and bME. To the base medium, the following factors were added: (i) ITS-CS: 1% ITS (Invitrogen), 1% FBS, 10 ng/ml TGF-b1 (PeproTech), 10 ng/ml BMP-2 (PeproTech), 50 mg/ml ascorbic acid (Sigma), (ii) ITS-basic: 1% ITS (Invitrogen), 1% FBS and (iii) FBS-CS: 15% FBS, 1 mg/ml insulin (Sigma), 10 ng/ml TGF-b1, 10 ng/ml BMP-2 and 50 mg/ml ascorbic acid. Medium was changed every day.
Cell viability. Cell viability was measured using the Vi-Cell XR (Beckman Coulter). Live/death cell number, viability and size were analyzed during differentiation in the different culture conditions. Only cells that were 2 mm or larger were sorted for analysis.
Alcian Blue staining. Proteoglycans secreted by chondrocyte-derived ESCs were stained with Alcian Blue. Cells were fixed in 4% paraformaldehyde for 15 min and washed twice with PBS-T (0.05% Tween-20 in PBS). They were then stained with Alcian Blue (1%, pH 1.0) for 30 min, followed by de-staining for 3 min in 0.1 N HCl, and washed twice with PBS-T before visualization.
GAG assay. To measure total GAG accumulation during differentiation in the different culture conditions, cultures including floating cells and aggregates were digested with 100 ml of papain digestion buffer (4.5 U/ml in 50 mM phosphate buffer, pH 6.5, with 2 mM N-acetylcysteine and 2 mM Na 2 EDTA; Sigma) for 4 h at 65 1C.
Values are calculated from a standard with chondroitin sulfate-A sodium salt (Sigma), which was measured along with the samples at 510 nm in a Benchmark Plus microplate spectrophotometer (Bio-Rad). The readings were then normalized to dsDNA content, which was measured using a Bio-Photometer (Eppendorf).
Calcium assay. To measure calcium accumulation during differentiation in the different culture conditions, cultures including floating cells and aggregates were digested with 100 ml of 10% formic acid. Values were calculated using the Arsenazo III (DCL), which was measured along with the samples at 650 nm in a Benchmark Plus microplate spectrophotometer. The readings were then normalized to dsDNA content, which was measured using a Bio-Photometer.
RNA isolation, RT-PCR. Total RNA was isolated from cell culture at 2, 4 and 6 days of differentiation using a RNeasy Mini kit (Qiagen) according to the manufacturer's instructions with on-column DNase I digestion. 32 The amount of total RNA was measured using a Bio-Photometer. Here, 1 mg of total RNA was used as a template for cDNA synthesis with Super Script III First-Strand Synthesis System (Invitrogen). The PCR reactions (20 ml) were carried out using Taq DNA Polymerase (Invitrogen) according to the manufacturer's instructions. PCR conditions were 3 min at 94 1C, 30 s denaturation at 94 1C, 45 s annealing at 55 1C and 1 min 30 s extension at 72 1C. Primers were designed based on the mouse sequence and BLASTed for their specificity at the National Center for Biotechnology Information (NCBI). Primer sequences and cycle number are described in Table 1 . Amplified PCR products were analyzed on a 1.5% agarose gel. Imaging and scanning were performed using VWR M-20E ultraviolet light source and photographed by Kodak MI Image system.
Immunofluorescence. Cells were fixed in 4% paraformaldehyde for 15 min and washed twice with PBS-T. After permeabilization with PBS containing 0.1% Triton-X, cells were washed twice with PBS-T, blocked with PBS containing 3% BSA for 1 h at room temperature, and incubated with primary antibody (Santa Cruz; 1:200) overnight at 4 1C. Then cells were washed three times with PBS-T, incubated with Alexa Flour 488-conjugated secondary antibody (1:500) and DAPI (1:500) for Loss of discordant cells during differentiation A Yamashita et al 2 h at room temperature. 33 Unbound secondary antibodies were removed by three washes with PBS-T. Fluorescent images were captured using a fluorescent microscope (IX70; Olympus, Japan) equipped with CCD camera (RT Color, Diagnostic, Spot Software V4.0.9).
In vivo cell implant assay. To determine the chondrogenic ability of cultured cells to differentiate in vivo, 4.5 Â 10 5 cells dissociated by 0.1% trypsin-EDTA were injected into the muscle of SCID mice, using a 27-gauge syringe. SCID mice were obtained from Taconic and housed in the single-barrier animal facility of the Faculty of Medicine, University of Calgary. 34 After 4 weeks, animals were killed and tissue at the point of injection was dissected. These specimens were fixed in 4% paraformaldehyde and decalcified in 10% EDTA (pH 8.0) solution. After dehydration in ascending concentrations of ethanol and xylene, the specimens were embedded in paraffin. The paraffin sections were then deparaffinized, hydrated and stained with hematoxylin and eosin (H&E), Alcian Blue and Alizarin Red S according to standard procedures.
TUNEL staining. To identify the apoptotic cells, TUNEL staining was performed with the in situ cell apoptosis detection kit according to the manufacturer's instructions (Roche). Briefly, the cells were fixed with 4% paraformaldehyde for 30 min. Terminal deoxynucleotidyl transferase (TdT) and biotin-11-dUTP reactions were performed for 1 h at 37 1C. Fluorescent images were captured using a fluorescent microscope equipped with CCD camera.
Annexin V-FITC/PI. To determine the rate of apoptosis, Annexin V-FITC/PI labeling was performed with the apoptosis detection kit I according to the manufacturer's instructions (BD Pharmingen). Briefly, the cells dissociated by 0.1% trypsin-EDTA were washed once with ice-cold PBS and resuspended in binding buffer at a concentration of 1.0 Â 10 6 cells/ml. Here, 5ml each of Annexin V-FITC and PI was added and incubated for 15 min in the dark prior to a further addition of 400 ml PBS. Quantitative analysis of apoptotic level was performed using a flow cytometer (Becton Dickinson, Franklin Lakes, NJ, USA). In total, 10 000 events were registered per sample with a FACS Calibur instrument and CellQuest software. 29 Early apoptosis were sorted by Annexin V-FITC positive and PI negative. Late apoptosis were sorted by Annexin V-FITC and PI positive.
Statistical analysis. Means±S.E.M. were calculated and statistically significant differences between two groups were determined using the Student's t-test at Po0.05 (Excel, Microsoft).
